Latest News for: pseudomonas aeruginosa

Edit

Glycovax Pharma is granted a licence by the National Research Council of Canada to develop a vaccine to fight nosocomial disease related to Pseudomonas aeruginosa (Pa) infections

PR Newswire 18 Aug 2025
MONTREAL, Aug. 18, 2025 /PRNewswire/ - Pseudomonas aeruginosa (Pa) is a bacterium responsible for nosocomial infections and is often fatal when contracted by people living with cystic fibrosis ... About Glycovax Pharma Inc ... www.glycovax.com ... 440k+ ... 9k+.
Edit

Epigenetic cellular memory in Pseudomonas aeruginosa generates phenotypic variation in response to host environments

PNAS 01 Jul 2025
Within a bacterial community, cells can exhibit ... .
  • 1

Article Search

tools
×
×
×
×